177 related articles for article (PubMed ID: 24050242)
1. Chemical screening platforms for autophagy drug discovery to identify therapeutic candidates for Huntington's disease and other neurodegenerative disorders.
Sarkar S
Drug Discov Today Technol; 2013; 10(1):e137-44. PubMed ID: 24050242
[TBL] [Abstract][Full Text] [Related]
2. Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers.
Sarkar S
Biochem Soc Trans; 2013 Oct; 41(5):1103-30. PubMed ID: 24059496
[TBL] [Abstract][Full Text] [Related]
3. Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy.
Tan CC; Yu JT; Tan MS; Jiang T; Zhu XC; Tan L
Neurobiol Aging; 2014 May; 35(5):941-57. PubMed ID: 24360503
[TBL] [Abstract][Full Text] [Related]
4. Targeting autophagy in neurodegenerative diseases.
Vidal RL; Matus S; Bargsted L; Hetz C
Trends Pharmacol Sci; 2014 Nov; 35(11):583-91. PubMed ID: 25270767
[TBL] [Abstract][Full Text] [Related]
5. [Effects of resveratrol-induced cellular autophagy in control of neurodegenerative diseases].
Dong W; Wang R
Yao Xue Xue Bao; 2016 Jan; 51(1):18-22. PubMed ID: 27405156
[TBL] [Abstract][Full Text] [Related]
6. Autophagy deregulation in neurodegenerative diseases - recent advances and future perspectives.
Cheung ZH; Ip NY
J Neurochem; 2011 Aug; 118(3):317-25. PubMed ID: 21599666
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling and therapeutic interventions in neurodegenerative diseases: a comprehensive study on potentiality and limits.
Benetti F; Gustincich S; Legname G
Expert Opin Drug Discov; 2012 Mar; 7(3):245-59. PubMed ID: 22468955
[TBL] [Abstract][Full Text] [Related]
8. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
Williams A; Jahreiss L; Sarkar S; Saiki S; Menzies FM; Ravikumar B; Rubinsztein DC
Curr Top Dev Biol; 2006; 76():89-101. PubMed ID: 17118264
[TBL] [Abstract][Full Text] [Related]
9. Small molecule enhancers of autophagy for neurodegenerative diseases.
Sarkar S; Rubinsztein DC
Mol Biosyst; 2008 Sep; 4(9):895-901. PubMed ID: 18704227
[TBL] [Abstract][Full Text] [Related]
10. Autophagic clearance of aggregate-prone proteins associated with neurodegeneration.
Sarkar S; Ravikumar B; Rubinsztein DC
Methods Enzymol; 2009; 453():83-110. PubMed ID: 19216903
[TBL] [Abstract][Full Text] [Related]
11. Autophagy-regulating small molecules and their therapeutic applications.
Baek KH; Park J; Shin I
Chem Soc Rev; 2012 Apr; 41(8):3245-63. PubMed ID: 22293658
[TBL] [Abstract][Full Text] [Related]
12. Autophagy in disease: a double-edged sword with therapeutic potential.
Martinet W; Agostinis P; Vanhoecke B; Dewaele M; De Meyer GR
Clin Sci (Lond); 2009 May; 116(9):697-712. PubMed ID: 19323652
[TBL] [Abstract][Full Text] [Related]
13. Drug screening for Huntington's disease and other neurodegenerative disorders.
Varma H
Curr Mol Pharmacol; 2010 Nov; 3(3):164-73. PubMed ID: 20858196
[TBL] [Abstract][Full Text] [Related]
14. Role of autophagy in prion protein-induced neurodegenerative diseases.
Yao H; Zhao D; Khan SH; Yang L
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):494-502. PubMed ID: 23459558
[TBL] [Abstract][Full Text] [Related]
15. Control of autophagy with small molecules.
Cho YS; Kwon HJ
Arch Pharm Res; 2010 Dec; 33(12):1881-9. PubMed ID: 21191751
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic screens targeting neurodegenerative diseases.
Zhang M; Luo G; Zhou Y; Wang S; Zhong Z
J Biomol Screen; 2014 Jan; 19(1):1-16. PubMed ID: 23958650
[TBL] [Abstract][Full Text] [Related]
17. Approaches for discovering novel bioactive small molecules targeting autophagy.
Hwang HY; Cho SM; Kwon HJ
Expert Opin Drug Discov; 2017 Sep; 12(9):909-923. PubMed ID: 28758515
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
19. It may be possible to delay the onset of neurodegenerative diseases with an immunosuppressive drug (rapamycin).
Aso E; Ferrer I
Expert Opin Biol Ther; 2013 Sep; 13(9):1215-9. PubMed ID: 23668915
[TBL] [Abstract][Full Text] [Related]
20. Modulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanisms.
Liu T; Bitan G
ChemMedChem; 2012 Mar; 7(3):359-74. PubMed ID: 22323134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
